Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives

Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives

The non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common cause of chronic liver disease as well as the first cause of liver transplantation. NAFLD is commonly associated with metabolic syndrome (MetS), and this is the most important reason why it is extremely difficult to tr...

Full description

Bibliographic Details
Main Authors: Grazia Pennisi, Ciro Celsa, Federica Spatola, Marcello Dallio, Alessandro Federico, Salvatore Petta
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:International Journal of Environmental Research and Public Health
Subjects:
non-alcoholic fatty liver disease
metabolic therapy
metabolic syndrome
Online Access:https://www.mdpi.com/1660-4601/16/22/4334

Similar Items

Similar Items